REFERENCE
Remák E, Muszbek N, Manson SC, Zlateva G, Chen C.Cost-effectiveness of cyclooxygenase-2 inhibitor parecoxib compared to opioids after noncardiac surgery in the United Kingdom. Value in Health 10: A230 (plus oral presentation) abstr. SU1, No. 6, Nov-Dec 2007
Rights and permissions
About this article
Cite this article
Parecoxib reduces postop resource use. Pharmacoecon. Outcomes News 540, 7 (2007). https://doi.org/10.2165/00151234-200705400-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705400-00010